Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Oral cyclosporine can help regrow hair in severe alopecia areata cases.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Squaric acid dibutylester effectively treats alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Younger patients with severe alopecia areata often have nail problems.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Scalp melanomas are more dangerous and likely to recur or cause death than other head and neck melanomas.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

The new AI software predicts melanoma outcomes more accurately than traditional methods.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Early diagnosis and treatment of Folliculitis decalvans are crucial, especially in younger patients and those with bacterial infections.

Skin cancer in sun-exposed areas is more likely to come back.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

The document concludes that different patterns of hair thickness and scalp changes can help diagnose types of non-scarring hair loss.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.